Caris Life Sciences, Inc. Common Stock
€13.35
EUR
Last updated on --.
24h volume2.00M
24h highest13.7911 EUR
24h lowest13.1635 EUR
24h Price movement-0.13%
CAI recent prices
24 Hours
-0.13%-€0.017196
30 days
-20.52%-€3.517
60 days
-8.20%-€1.196
90 days
-17.67%-€2.924
Key data
Previous close13.3699 EUR
Market cap3.82B EUR
Volume2.00M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount0.25794 EUR
Next ex-dividend date9 Sept 2021
Next payment date27 Sept 2021
EPS diluted (TTM)-1.2553 EUR
Net income (FY)29.22M EUR
Revenue (FY)780.09M EUR
Last report date8 May 2026
About Caris Life Sciences, Inc. Common Stock
HeadquartersIRVING
Employees (FY)1.85K
Revenue per employee (FY)422.58K EUR
Net income per employee (FY)15.83K EUR
Listed onNasdaq
CAI conversion tables
 |  |
|---|---|
| 0.5 CAI | 6.676 EUR |
| 1 CAI | 13.35 EUR |
| 5 CAI | 66.76 EUR |
| 10 CAI | 133.52 EUR |
| |
|---|---|
| 0.5 EUR | 0.037446 CAI |
| 1 EUR | 0.074891 CAI |
| 5 EUR | 0.37446 CAI |
| 10 EUR | 0.74891 CAI |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
CAI is trading at €13.35, -0.13% over the last 24 hours. Track live moves on the price chart at the top of this page.
The CAI stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. CAI is currently trading at €13.35, -0.13% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on CAI price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the SERVICES-MEDICAL LABORATORIES sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. CAI's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from CAI; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against CAI's historical range and other companies in the SERVICES-MEDICAL LABORATORIES sector.
Caris Life Sciences, Inc. Common Stock's market cap is currently 3.82B EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume2.00M
24h highest13.7911 EUR
24h lowest13.1635 EUR
24h Price movement-0.13%
Start trade with CAI Perpetual
Sign up to trade